CVRx® Raises $50 Million in New Equity Financing.

July 7, 2020
Porfolio-CVRx.png

CVRx, Inc., a private medical device company with a novel technology that treats patients suffering from chronic heart failure (“HF”) and resistant hypertension, announced today that it raised $50 million to close its latest round of equity financing.

SAN FRANCISCO   |   IRELAND


SAN FRANCISCO   |   IRELAND


Copyright 2020 Strategic Healthcare Investment Partners. All rights reserved.